Target intelligence / Profile preview

GALNT18 antisense RNA 1 (GALNT18-AS1)

Target: GALNT18-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

GALNT18 antisense RNA 1 (GALNT18-AS1) is a predicted long non-coding RNA gene that is transcribed in the antisense direction relative to the GALNT18 gene, which codes for polypeptide N-acetylgalactosaminyltransferase 18, an enzyme involved in O-linked glycosylation. While antisense RNAs have established roles in modulating the expression of their associated sense genes primarily through chromatin modification, transcript stability, or transcriptional interference, there is no published functional characterization, disease association, or therapeutic relevance for GALNT18-AS1 specifically.

Other names: GALNT18-AS1

Biological functions

Gene expression regulation

Beyond the preview

Go deeper on GALNT18 antisense RNA 1 (GALNT18-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GALNT18 antisense RNA 1 (GALNT18-AS1).

Explore the full profile